Companies similar to DYNE THERAPEUTICS INC (DYN)
Health Care · NASDAQ
DYNE THERAPEUTICS INC (DYN)'s closest peers include Sarepta Therapeutics (SRPT), Biogen (BIIB), Regeneron Pharmaceuticals (REGN), VERTEX INC CLASS A (VERX) and SOLID BIOSCIENCES INC (SLDB). This peer set is drawn from DYN's enriched company profile and is informational only — not financial advice.
Similar companies
-
Sarepta TherapeuticsSRPTHealth Care
Sarepta is a rare-disease biotech focused on genetic therapies for muscular dystrophies, powered by antisense and gene therapy platforms.
$17.23 (as of 2026-07-16) · market cap $1.8B
-
BiogenBIIBHealth Care
Biogen is a global biotechnology company developing and commercializing therapies across neurology, immunology, and rare genetic disease.
$208.92 (as of 2026-07-16) · market cap $30.3B
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$678.94 (as of 2026-07-16) · market cap $70.5B
-
VERTEX INC CLASS AVERXInformation Technology
Vertex automates and governs transaction-based indirect tax compliance across 195 countries for enterprises, embedded into their commerce systems to handle…
$13.16 (as of 2026-07-16) · market cap $2.1B
-
SOLID BIOSCIENCES INCSLDBHealth Care
A gene therapy company advancing a pipeline of treatments for rare neuromuscular and cardiac diseases including Duchenne muscular dystrophy, Friedreich's…
$9.05 (as of 2026-07-16) · market cap $885M
Not quite? Describe exactly what you want →
Peers are drawn from DYN's enriched profile (the same similarity signal the chat uses for "companies like DYN"). See the full profile: DYNE THERAPEUTICS INC (DYN).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.